Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Tigermed and MSD China Sign LOI for Clinical Trial Services

publication date: Aug 23, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Hangzhou Tigermed Consulting, a China CRO, signed a letter of intent with MSD China that calls for Tigermed to provide MSD with clinical trial services for a three-year period, from August 15, 2012 to July 31, 2015. Neither the range of services, the type of drug(s) involved, nor the financial details of the relationship were disclosed, probably awaiting a closing agreement. MSD is the name for Merck outside of the US and Canada. More details....

Stock Symbols: (SHE: 300347) (NYSE: MRK)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners